APA (7th ed.) Citation

B, T., DA, Y., ZH, L., T, W., TI, M., RL, S., . . . G, Z. (2013). Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: Metabolic basis and potential clinical implications. The Journal of biological chemistry, 288(5), 3500. https://doi.org/10.1074/jbc.M112.394510

Chicago Style (17th ed.) Citation

B, Tan, et al. "Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, in Human Cancer Cells: Metabolic Basis and Potential Clinical Implications." The Journal of Biological Chemistry 288, no. 5 (2013): 3500. https://doi.org/10.1074/jbc.M112.394510.

MLA (9th ed.) Citation

B, Tan, et al. "Pharmacological Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, in Human Cancer Cells: Metabolic Basis and Potential Clinical Implications." The Journal of Biological Chemistry, vol. 288, no. 5, 2013, p. 3500, https://doi.org/10.1074/jbc.M112.394510.